ClinicalTrials.gg
Enrolling by invitationNCT07112040ASSYST-SVUpdated Oct 20, 2026

The Effectiveness of a Brief Early Intervention of Acute Stress Syndrome Stabilization Protocol for Victims of Sexual Violence (ASSYST-SV).

An interventional study of Behavioral - ASSYST-VS Protocol in Acute Stress Symptoms and Sexual Violence, sponsored by Universidad Complutense de Madrid. Enrolling by invitation at 1 site in Spain. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Universidad Complutense de Madrid · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jan 2025, registered Aug 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

TThe main objectives of this research project are twofold: (1) to conduct a narrative review of the scientific literature on the efficacy and effectiveness of psychological interventions for reducing acute post-traumatic stress symptoms in survivors of sexual violence, and to provide a solid theoretical framework on the consequences of sexual victimization and the use of EMDR interventions in this population; and (2) to develop and test an adapted version of the ASSYST protocol of Jarero´s team for survivors of sexual violence (ASSYST-SV), evaluating its effectiveness and feasibility in reducing acute stress symptoms in women who have experienced sexual violence.

This is an exploratory quasi-experimental study with a single-group pre-post design and follow-up assessments. The intervention will be delivered to women receiving care in specialized services for survivors of gender-based violence in Catalonia and Madrid. Assessments will be conducted at three time points: pre-intervention, post-intervention, and three-month follow-up. Data will be collected through a combination of clinician-administered and self-report questionnaires.

This trial is part of a larger research project (NCT05619822) that includes several related studies. Each study addresses a specific population and/or intervention, but all share the overarching aim of examining the efficacy of a comprehensive third-generation protocol for individuals with comorbid trauma and other mental health conditions.

Read the detailed description

Sexual violence is associated with a high risk of developing post-traumatic stress disorder (PTSD), emotional distress, sleep disturbances, and impairments in daily functioning. Despite these risks, few interventions are tailored to the specific needs of women who have experienced sexual violence, particularly in the acute phase. This study aims to address this gap by adapting the ASSYST protocol-originally developed for trauma-related acute stress-and evaluating its utility in real-world clinical settings.

The ASSYST-VS protocol consists of five 90-minute sessions. The first session focuses on psychoeducation and emotional regulation using trauma-sensitive yoga techniques (YST) to promote safety and establish a therapeutic alliance. Sessions two through five focus on desensitizing the traumatic event using an EMDR-informed version of the ASSYST protocol adapted for this population.

Given the high risk of psychopathology following sexual violence, no control group will be included for ethical reasons. Participants will be recruited from Specialized Intervention Services (SIE) in Catalonia and CAPSEM centers in Madrid. Following informed consent, participants will complete both clinician-administered and self-report assessments measuring PTSD symptoms, anxiety, depression, sleep quality, emotional well-being, and functional capacity. All study procedures will adhere to strict confidentiality protocols and comply with the General Data Protection Regulation (GDPR).

Feasibility will be assessed through adherence and dropout rates, as well as participant satisfaction. The expected sample size (n = 36) is based on previous studies with similar interventions and was calculated using G*Power to ensure adequate statistical power.

Primary outcomes include changes in PTSD symptoms (International Trauma Questionnaire, ITQ), emotional distress (Generalized Anxiety Disorder Scale, GAD-7; Patient Health Questionnaire, PHQ-9), functional impairment (Inadaptation Scale), sleep problems (Pittsburgh Sleep Quality Index, PSQI), and well-being (Warwick-Edinburgh Mental Well-being Scale, WEMWBS). Participant satisfaction will be measured with the Client Satisfaction Questionnaire (CSQ). This project seeks to provide evidence for a scalable, early-phase trauma intervention with high clinical relevance.

02

Conditions studied

  • Acute Stress Symptoms
  • Sexual Violence

Browse trials for

Keywords

  • ASSYST protocol
  • Acute stress
  • trauma
  • individual intervention
  • survivors of sexual violence
03

In context

Wounds and Injuries

2,221 studies on the registry are indexed under Wounds and Injuries; 442 are open to participants now.

This study's planned enrollment of 36 is below the median of 70 across 1,426 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Universidad Complutense de Madrid is the lead sponsor of 206 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be a woman aged 18 or older
  • Have experienced at least one episode of sexual violence within the past 6 months
  • Be currently receiving care from one of the following centers:
  • Servei d'Intervenció Especialitzada (SIE) in Garraf-Penedès or Baix Llobregat (Catalonia)
  • CAPSEM Norte or CAPSEM Sur (Madrid)
  • Present acute post-traumatic stress symptoms (score > 0 on items 3.1 to 3.5 of the Trauma Screening Questionnaire - TSQ)
  • Be capable and willing to provide
  • Be fluent in Spanish or Catalan The intervention is offered under the assumption that women seeking support from specialized services are in need of early psychological intervention, and may benefit from a brief trauma-focused approach. This inclusive design seeks to maximize access to care and promote recovery in real-world settings.

Exclusion criteria

Exclusion Criteria:

  • Active substance abuse that would interfere with treatment participation
  • Intellectual or cognitive disability that prevents completion of the intervention protocol
  • Active suicidal ideation at the time of the intervention
  • Inability to communicate in Spanish or Catalan
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    ASSYST-VS Intervention

    This is a single-arm study. All participants will receive the ASSYST-SV intervention, a brief, trauma-focused psychological protocol adapted for adult women who have experienced sexual violence within the previous six months. No waitlist or control condition is included due to ethical considerations.

    Behavioral: Behavioral - ASSYST-VS Protocol

Interventions

  • BehavioralBehavioral - ASSYST-VS Protocol

    The ASSYST-SV protocol consists of three sessions, each lasting approximately 90 minutes, ideally delivered once per week over a three-week period. The intervention includes: Session 1: Psychoeducation: Explanation of typical responses to sexual trauma, providing information about the recovery process, and establishing a strong therapeutic alliance between the client and therapist. Sessions 1-3: Emotional self-regulation using trauma-sensitive yoga exercises adapted for survivors of sexual violence. Sessions 2-3: Trauma desensitization using EMDR-informed techniques, including bilateral stimulation and self-applied tools such as the Butterfly Hug. Safety procedures and closure are included in all sessions to ensure emotional containment and promote participant well-being. The intervention is delivered by trained professionals in specialized support services for victims of gender-based violence.

06

What researchers measure

Primary outcomes

  1. Change in posttraumatic stress symptoms

    International Trauma Questionnaire (ITQ; Cloitre et al., 2018) Post-Traumatic Stress Disorder (PTSD) and Complex PTSD (CPTSD) symptoms based on ICD-11 criteria. Administration: Self-administered online via a Qualtrics link. Interpretation: Higher scores indicate greater symptom severity of PTSD and CPTSD

    Time frame: Before the intervention (baseline) Immediately after the intervention (3 weeks) 3-month follow-up

Secondary outcomes

  1. Changes in anxiety symptoms

    Generalized Anxiety Disorder-7 (GAD-7; Spitzer et al., 2006; Spanish version by García-Campayo et al., 2010) Symptoms of generalized anxiety experienced over the past two weeks. Administration: Self-administered online with support available if needed. Interpretation: Higher scores indicate greater levels of generalized anxiety.

    Time frame: Baseline Post-intervention (3 weeks) 3-month follow-up

  2. Changes in depression symptoms

    Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001; Spanish version by Díez-Quevedo et al., 2001) Depressive symptoms experienced over the past two weeks. Administration: Self-administered via Qualtrics. Interpretation: Higher scores indicate more severe depressive symptoms.

    Time frame: Baseline Post-intervention (3 weeks) 3-month follow-up

  3. Changes in sleep dimensions

    Pittsburgh Sleep Quality Index - Short Version (PSQI; Buysse et al., 1989) Sleep quality and patterns, including sleep duration, latency, efficiency, disturbances, and daytime dysfunction. Administration: Self-administered. Interpretation: Higher scores indicate poorer sleep quality.

    Time frame: Baseline Post-intervention (3 weeks) 3-month follow-up

  4. Changes in general Impairment

    General Impairment Index (Índice de Inadaptación General; Echeburúa, Corral \& Fernández-Montalvo, 2000) The degree of functional impairment or maladjustment in daily life, including personal, social, and work domains.Administration: Self-administered online, with professional assistance if necessary. Interpretation: Higher scores reflect greater difficulties in daily functioning.

    Time frame: Baseline Post-intervention (3 weeks) 3-month follow-up

  5. Changes in wellbeing

    Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS; Tennant et al., 2007) Positive mental wellbeing, including positive affect, psychological functioning, and interpersonal relationships. Administration: Self-administered via Qualtrics. Interpretation: Higher scores indicate better mental wellbeing.

    Time frame: Baseline Post-intervention (3 weeks) 3-month follow-up

  6. Satisfaction with the intervention

    Client Satisfaction Questionnaire-8 (CSQ-8; Attkisson \& Zwick, 1982) Participant satisfaction with the intervention, including perceived effectiveness, quality, and willingness to recommend. Administration: Self-administered online. Interpretation: Higher scores indicate greater satisfaction with the intervention.

    Time frame: Only after the intervention (3 weeks)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Jun 2026, 17 months.

Of 546 non-industry interventional studies with no phase under Wounds and Injuries, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 49. This study's 17 months is below that.

Counting every sponsor, half of 599 studies reached it within 24 months; a quarter within 9 and three quarters within 48.

Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 1, 2025
First posted
Aug 8, 2025
StartActual
Jan 1, 2025
Primary completionActual
Jun 30, 2026
CompletionEst.
Dec 31, 2027
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and date precision
1 update, last Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Minor edits only
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07112040
Collaborators
EMDR Europe
Responsible party
Sponsor
First posted
Aug 8, 2025
Start date
Jan 1, 2025
Primary completion
Jun 30, 2026
Completion
Dec 31, 2027 (estimated)
Last update
Oct 20, 2026

Study contacts

Carmen Valiente, Full Porfessor
principal investigator · Universidad Complutense de Madrid
Yolanda Ballesteros Gonzalez, PhD student
principal investigator · Universidad Complutense de Madrid
Regina Espinosa, Full Porfessor
principal investigator · Camilo Jose Cela University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion